Khandan Keyomarsi, PhD: Cyclin-E and resistance to breast cancer oncotherapy
Khandan Keyomarsi, PhD, Professor in Medical Oncology at The University of Texas’ MD Anderson Cancer Center discusses her recent paper on the role of Low Molecular Weight Cyclin-E in causing breast cancer cells to become resistant to certain cancer fighting drugs given to ER+ breast cancer patients.
MD Anderson, Oncology | apples49 | 
February 20, 2010 2:29 pm
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI
